Home › Trial NCT05370469
Real-Time Monitoring of Symptoms in Lung Cancer Patients Receiving Oral Targeted Therapies
- Trial IDNCT05370469
- StatusActive Not Recruiting
- PhaseN/A
- Study typeInterventional
- SponsorUniversity of Virginia
- Enrollment30
- Start date2022-08-25
- ConditionsLung Cancer · EGFR Gene Mutation · EGFR · ALK Gene Mutation · RET Gene Mutation · MET Gene Mutation
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.